AR066054A1 - Proceso para preparar galantamina - Google Patents

Proceso para preparar galantamina

Info

Publication number
AR066054A1
AR066054A1 ARP080101531A ARP080101531A AR066054A1 AR 066054 A1 AR066054 A1 AR 066054A1 AR P080101531 A ARP080101531 A AR P080101531A AR P080101531 A ARP080101531 A AR P080101531A AR 066054 A1 AR066054 A1 AR 066054A1
Authority
AR
Argentina
Prior art keywords
formula
compound
hydroxyphenyl
ethyl
methyl
Prior art date
Application number
ARP080101531A
Other languages
English (en)
Inventor
Yung Fa Chen
Julian Paul Henschke
Original Assignee
Scinopharm Taiwan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Taiwan Ltd filed Critical Scinopharm Taiwan Ltd
Publication of AR066054A1 publication Critical patent/AR066054A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/73—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems

Abstract

Un proceso para la preparacion de N-metil-N-(2-[4-hidroxifenil]etil)-5-hidroxi-4-metoxibencencarboxamida, que es de utilidad como un intermediario en la síntesis de (-)-galantamina, que comprende la reaccion de un derivado de ácido 5-hidroxi-4-metoxibenzoico con N-metil-N-(2-[4-hidroxifenil]etil)amina. Reivindicacion 1: Un proceso para la preparacion de un compuesto de la formula (1) en donde Z es un grupo de bloqueo, caracterizado porque comprende: 1) activar un compuesto de la formula(2) en donde Z es como se definio con anterioridad, con un agente de acoplamiento para dar un compuesto activado de la formula (3) en donde X es un grupo saliente resultante del uso del agente de acoplamiento, y 2) acoplar el compuesto activado dela formula (3) con un compuesto N-metil-N-(2-[4-hidroxifenil]etil)amina de formula (4) o una sal ácida del compuesto de formula (4) para dar el compuesto de la formula 1.
ARP080101531A 2007-04-12 2008-04-11 Proceso para preparar galantamina AR066054A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92319107P 2007-04-12 2007-04-12

Publications (1)

Publication Number Publication Date
AR066054A1 true AR066054A1 (es) 2009-07-22

Family

ID=39854337

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080101531A AR066054A1 (es) 2007-04-12 2008-04-11 Proceso para preparar galantamina

Country Status (14)

Country Link
US (1) US7985879B2 (es)
EP (1) EP2146719B1 (es)
JP (1) JP5441883B2 (es)
KR (1) KR101172044B1 (es)
CN (1) CN101674835B (es)
AR (1) AR066054A1 (es)
AU (1) AU2008239730B2 (es)
CA (1) CA2683098C (es)
ES (1) ES2432405T3 (es)
NZ (1) NZ580271A (es)
PL (1) PL2146719T3 (es)
SI (1) SI2146719T1 (es)
TW (1) TWI343909B (es)
WO (1) WO2008127560A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532149B (zh) * 2011-12-14 2015-05-13 南开大学 加兰他敏和力可拉敏的不对称合成方法
CN113292420A (zh) * 2021-05-27 2021-08-24 神隆医药（常熟）有限公司 加兰他敏中间体原料2-溴-5-羟基-4-甲氧基苯甲酸回收方法
CN113620821A (zh) * 2021-09-01 2021-11-09 广汉市派瑞林科技有限责任公司 一种大麦芽碱盐酸盐的制备方法
CN113683491A (zh) * 2021-09-01 2021-11-23 王传良 一种4-(2-溴乙基)苯酚的制备方法
CN113683522A (zh) * 2021-09-01 2021-11-23 广汉市派瑞林科技有限责任公司 一种n-甲基酪胺盐酸盐的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514679D0 (en) * 1985-06-11 1985-07-10 Beecham Group Plc Compounds
US5831002A (en) 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
JP4187786B2 (ja) * 1994-10-21 2008-11-26 ザノヒェミア・ファルマツォイティカ・アー・ゲー ４ａ，５，９，１０，１１，１２−ヘキサヒドロ−６Ｈ−ベンゾフロ［３ａ，３，２−ｅｆ］［２］ベンズアゼピン誘導体の製造方法
GB9506843D0 (en) 1995-04-03 1995-05-24 Chiroscience Ltd Oxidative process and products thereof
US7307162B2 (en) * 2003-09-26 2007-12-11 Scinopharm Taiwan, Ltd. Resolution of a narwedine amide derivative
US20060009640A1 (en) * 2004-07-08 2006-01-12 Bolugoddu Vijaya B Preparation of (-)-galantamine hydrobromide
JP2007039466A (ja) * 2004-11-29 2007-02-15 Japan Tobacco Inc 窒素含有縮合環化合物及びその用途
WO2006072818A2 (en) * 2005-01-04 2006-07-13 Emcure Pharmaceuticals Limited Process for preparation of galanthamine
US20080306257A1 (en) * 2005-05-03 2008-12-11 Medichem, S.A. Syntheses and Preparations of Narwedine and Related Novel Compounds

Also Published As

Publication number Publication date
ES2432405T3 (es) 2013-12-03
US20080255347A1 (en) 2008-10-16
KR101172044B1 (ko) 2012-08-08
EP2146719A4 (en) 2012-07-04
KR20100015748A (ko) 2010-02-12
CA2683098A1 (en) 2008-10-23
AU2008239730B2 (en) 2011-10-06
EP2146719A1 (en) 2010-01-27
TWI343909B (en) 2011-06-21
PL2146719T3 (pl) 2013-12-31
CA2683098C (en) 2014-03-18
NZ580271A (en) 2011-03-31
US7985879B2 (en) 2011-07-26
JP2010523658A (ja) 2010-07-15
CN101674835B (zh) 2013-12-11
EP2146719B1 (en) 2013-08-14
AU2008239730A1 (en) 2008-10-23
SI2146719T1 (sl) 2013-10-30
TW200902483A (en) 2009-01-16
CN101674835A (zh) 2010-03-17
JP5441883B2 (ja) 2014-03-12
WO2008127560A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
UY32062A (es) Inhibidores de beta-secretasa
ECSP10010496A (es) Derivado heterociclico fusionado y su uso
BRPI0612957B8 (pt) composto, processos de preparação de compostos, composição farmacêutica e uso de um composto
AR074845A1 (es) Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
BRPI0712631B8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
BRPI0720993B8 (pt) usos de compostos análogos de ciclopamina
UA97351C2 (ru) Производная кумарина, имеющая противоопухолевую активность
DOP2006000170A (es) Nuevos derivados de espirocromanona
UY32648A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de enfermedades
PE20061447A1 (es) Tigeciclina y metodos para preparar 9-aminominociclina
CL2007001784A1 (es) Compuestos derivados de benzoxazol de formula la, su composicion farmaceutica, metodo para medir in vivo depositos de amoloide empleando dicha composicion, y uso del compuesto la para preparar un medicamento, y compuesto de formula ib, y su uso como precursor en la preparacion de un compuesto marcado.
AR078522A1 (es) Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
UY30824A1 (es) Nuevos derivados de idazolil éster o amida, composiciones farmacéuticas conteniéndolas, procesos de preparacion y aplicaciones.
BRPI0708685B8 (pt) composto de 4-oxoquinolina, seu uso e método para produção dos mesmos
MY172860A (en) Dimethyl-benzoic acid compounds
UY31502A1 (es) Proceso mejorado para sintetizar 5-cyclopentyl-5-11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-5-ol usando tmeda
AR067770A1 (es) Derivados de tiazol y ditiazol para el tratamiento de diabetes
ECSP10010192A (es) 5-[(3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su producción y su uso como agentes antiinflamatorios
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
UY29510A1 (es) Derivados de urea, metodos para su fabricación, y usos de los mismos
AR066054A1 (es) Proceso para preparar galantamina
AR079050A1 (es) Compuestos benzoimidazolicos y sus usos
ECSP099070A (es) Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
AR074545A1 (es) Proceso de preparacion de dihidroetorfina

Legal Events

Date Code Title Description
FB Suspension of granting procedure